MedTrace Logo

Epidemiology Study of Malaria Transmission Intensity in Africa

NCT01190202 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21618

Last updated 2020-08-18

Study results available
· View outcomes & findings →

Summary

The aim of this epidemiology study is to characterize in a standardized way malaria transmission intensity at the clinical trial centers participating in study 110021 (NCT00866619).

Conditions

Interventions

PROCEDURE

Blood sampling

Capillary blood samples collected by finger/heel prick

PROCEDURE

Assessment of body temperature

Assessment of axial body temperature with a digital thermometer

Sponsors & Collaborators

  • The PATH Malaria Vaccine Initiative (MVI)

    collaborator OTHER

  • GlaxoSmithKline

    lead INDUSTRY

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
NA
Purpose
OTHER
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-14
Primary Completion
2013-12-20
Completion
2013-12-20

Countries

  • Burkina Faso
  • Gabon
  • Ghana
  • Kenya
  • Malawi
  • Tanzania

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01190202 on ClinicalTrials.gov